LOCALLY D-OPTIMAL DESIGNS BASED ON A CLASS OF COMPOSED MODELS RESULTED FROM BLENDING EMAX AND ONE-COMPARTMENT MODELS ⁄
暂无分享,去创建一个
[1] J. Wakefield. The Bayesian Analysis of Population Pharmacokinetic Models , 1996 .
[2] Thomas M. Ludden,et al. Pharmacokinetics of Quinidine in Male Patients , 1992, Clinical pharmacokinetics.
[3] N. White,et al. Oral Artesunate Dose-Response Relationship in Acute Falciparum Malaria , 2002, Antimicrobial Agents and Chemotherapy.
[4] J L Palmer,et al. Bayesian optimal design in population models for haematologic data. , 1998, Statistics in medicine.
[5] W. J. Studden,et al. Theory Of Optimal Experiments , 1972 .
[6] W. J. Studden,et al. Tchebycheff Systems: With Applications in Analysis and Statistics. , 1967 .
[7] B. Steiger,et al. Hydralazine dose-response curve analysis , 1990, Journal of Pharmacokinetics and Biopharmaceutics.
[8] Alain Mallet,et al. Optimal design in random-effects regression models , 1997 .
[9] I. Trocóniz,et al. Population Dose-Response Model for Tadalafil in the Treatment of Male Erectile Dysfunction , 2004, Pharmaceutical Research.
[11] Holger Dette,et al. Bayesian D-optimal designs for exponential regression models , 1997 .
[12] L. White. An extension of the General Equivalence Theorem to nonlinear models , 1973 .
[13] A. Hedayat,et al. Optimal and efficient designs for 2-parameter nonlinear models☆ , 2004 .
[14] W. Ritschel. Handbook of basic pharmacokinetics , 1976 .
[15] B. E. Rodda,et al. The One-compartment Open Model: Some Statistical Aspects of Parameter Estimation , 1975 .
[16] Marie Davidian,et al. Smooth nonparametric maximum likelihood estimation for population pharmacokinetics, with application to quinidine , 1992, Journal of Pharmacokinetics and Biopharmaceutics.
[17] J. Lindsey,et al. Generalized Nonlinear Models for Pharmacokinetic Data , 2000, Biometrics.
[18] Kathryn Chaloner,et al. Bayesian Experimental Design for Nonlinear Mixed‐Effects Models with Application to HIV Dynamics , 2004, Biometrics.
[19] Drew Seils,et al. Optimal design , 2007 .
[20] Kathryn Chaloner,et al. D- and c-optimal designs for exponential regression models used in viral dynamics and other applications , 2003 .
[21] A. Hedayat,et al. Optimum designs for estimating EDp based on raw optical density data , 2002 .
[22] Lewis B. Sheiner,et al. Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects , 1992, Journal of Pharmacokinetics and Biopharmaceutics.
[23] Isadore Kanfer,et al. Evaluation of the Proposed FDA Pilot Dose-Response Methodology for Topical Corticosteroid Bioequivalence Testing , 2004, Pharmaceutical Research.
[24] Malcolm Rowland,et al. Clinical pharmacokinetics : concepts and applications , 1989 .
[25] J. Kiefer,et al. The Equivalence of Two Extremum Problems , 1960, Canadian Journal of Mathematics.
[26] A. S. Hedayat. Study of Optimality Criteria in Design of Experiments. , 1980 .
[27] K. Chaloner,et al. Optimum experimental designs for properties of a compartmental model. , 1993, Biometrics.
[28] A. S. Hedayat,et al. Modeling and Identifying Optimum Designs for Fitting Dose-Response Curves Based on Raw Optical Density Data , 1997 .